McKesson gemcitabine injection recalled for improper storage
One lot of McKesson gemcitabine injection, a single-dose vial for intravenous infusion, was stored at controlled room temperature instead of in a refrigerator. The recall covers 74 units of lot CB0046. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Set aside any vials from lot CB0046 (exp. 06/2027) and do not administer them.
- Check the NDC on vial labels: 0143-9341-01 identifies the product.
- The notice doesn't say how to get a replacement or refund; contact McKesson or Hikma.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- 74 units
- Illnesses reported
- None reported
- Manufactured in
- 6555 State Highway 161, N/A, Irving, TX, United States
- Classification
- Class II
- Recall number
- D-0714-2026
In the FDA's words
- Description
- Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01 Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment. Lot #: CB0046, Exp. Date 06/2027 Distribution: Nationwide within the United States Affected quantity: 74 units
- Hazard
- Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.